ir.supernus.comInvestor Relations - Supernus Pharmaceuticals
ir.supernus.com Profile
Ir.supernus.com is a subdomain of supernus.com, which was created on 2002-07-29,making it 22 years ago.
Description：The Investor Relations website contains information about Supernus Pharmaceuticals's business for stockholders, potential investors, and financial...
Discover ir.supernus.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.supernus.com Information
| HomePage size: 36.472 KB |
| Page Load Time: 0.830449 Seconds |
| Website IP Address: 23.38.226.127 |
ir.supernus.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
ir.supernus.com PopUrls
| Supernus Pharmaceuticals: Investor Relations https://ir.supernus.com/ |
| node https://ir.supernus.com/node |
| Search https://ir.supernus.com/search |
| 0001356576-21-000097 | 8-K | iXBRL Viewer https://ir.supernus.com/node/12691/ixbrl-viewer |
| Press Releases - Supernus Pharmaceuticals https://ir.supernus.com/press-releases |
| Supernus Announces Fourth Quarter and Full Year 2022 Financial Results https://ir.supernus.com/news-releases/news-release-details/supernus-announces-fourth-quarter-and-full-year-2022-financial |
| Financials & Filings - Supernus Pharmaceuticals https://ir.supernus.com/financial-information |
| Quarterly Results - Supernus Pharmaceuticals https://ir.supernus.com/financial-information/quarterly-results |
| Supernus Announces Preliminary Fourth Quarter and Full Year 2021 ... https://ir.supernus.com/news-releases/news-release-details/supernus-announces-preliminary-fourth-quarter-and-full-year-2021 |
| Events & Presentations - Supernus Pharmaceuticals https://ir.supernus.com/events-and-presentations |
ir.supernus.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Security-Policy: report-uri //report-csp-violation |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1579953267" |
| From-Origin: same |
| Last-Modified: Sat, 25 Jan 2020 11:54:27 GMT |
| Link: http://ir.supernus.com/; rel="shortlink", http://ir.supernus.com/; rel="canonical", http://ir.supernus.com/investor-relations; rel="alternate"; hreflang="en", http://ir.supernus.com/investor-relations; rel="revision" |
| Server: nginx |
| X-Age: 0 |
| X-Content-Security-Policy: report-uri //report-csp-violation |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-701d3f4e-3f69-11ea-896d-cbd2536943ce |
| X-UA-Compatible: IE=edge |
| X-WebKit-CSP: report-uri //report-csp-violation |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 9030 |
| X-EdgeConnect-MidMile-RTT: 37 |
| X-EdgeConnect-Origin-MEX-Latency: 292 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Sat, 25 Jan 2020 11:54:27 GMT |
| Date: Sat, 25 Jan 2020 11:54:27 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: SimpleSAMLSessionID=1a76a9293d6c2fd142f8d92117233c2e; path=/; secure; HttpOnly, DrupalVisitorMobile=0; path=/ |
ir.supernus.com Meta Info
| charset="utf-8"/ |
| content="Investor Relations - Supernus Pharmaceuticals" name="title"/ |
| content="Supernus Pharmaceuticals" property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about Supernus Pharmaceuticals's business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="http://ir.supernus.com/investor-relations" property="og:url"/ |
| content="Investor Relations | Supernus Pharmaceuticals" property="og:title"/ |
| content="The Investor Relations website contains information about Supernus Pharmaceuticals's business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
ir.supernus.com Ip Information
| Ip Country: United States |
| City Name: Santa Clara |
| Latitude: 37.353 |
| Longitude: -121.9543 |
ir.supernus.com Html To Plain Text
Investors Investors Press Releases Press Releases Events and Presentations Events & Presentations Corporate Governanace Corporate Governance Other Related Links Management Board of Directors Committee Composition Contact the Board Financials and Filings Financials & Filings Other Related Links SEC Filings Annuals and Proxies Quarterly Results Stock Information Stock Information Other Related Links Historic Stock Lookup Investment Calculator Ownership Profile Investor FAQ’s Investor FAQ’s Contact Us Contact Us A Legacy of Innovation, a portfolio of promise™ © 2020 Supernus Pharmaceuticals, Inc. Sitemap Terms of Use Privacy Policy Investor Relations Investor Relations IR.Supernus.com SUPN - SUPN Supernus Pharmaceuticals, Inc. Change : Day High : Day Low : Volume : 6:54 AM EST on Jan 25, 2020 Copyright nasdaq. Minimum 15 minutes delayed. SUPN Frontpage Menu Press Releases Events & Presentations Corporate Governance Financials & Filings FAQ’s Stock Information Contact Us © 2020 Supernus Pharmaceuticals,...
ir.supernus.com Whois
Domain Name: SUPERNUS.COM Registry Domain ID: 88829583_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2024-02-02T18:23:40Z Creation Date: 2002-07-29T13:45:08Z Registry Expiry Date: 2024-07-29T13:45:08Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS10.DIGICERTDNS.COM Name Server: NS11.DIGICERTDNS.COM Name Server: NS12.DIGICERTDNS.COM Name Server: NS13.DIGICERTDNS.NET Name Server: NS14.DIGICERTDNS.NET Name Server: NS15.DIGICERTDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:06:07Z <<<